Investment consortium nears deal for Syneos Health-sources

Syneos Health

09/05/2023 21:12

NEW YORK, May 9 (Reuters) - A consortium comprising
Elliott Investment Management, Patient Square Capital and
Veritas Capital is nearing a deal to acquire Syneos Health Inc
 SYNH.O , a provider of clinical research to drug developers
with a market value of $4 billion, people familiar with the
matter said.
    The price that the consortium is paying for Syneos could not
be learned. The sources requested anonymity because the matter
is confidential. Syneos and the investment firms did not
immediately respond to requests for comment. Bloomberg News
first reported the news.  
    

 (Reporting by Anirban Sen in New York)
 ((Greg.Roumeliotis@thomsonreuters.com; +1 646 223 6022; Reuters
Messaging: greg.roumeliotis.thomsonreuters.com@reuters.net))